TrialScientific reports2024

Comparison of the efficacy and safety of SCD411 and reference aflibercept in patients with neovascular age-related macular degeneration.

Se Woong Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.